An oncologist evaluates a -year-old hospitalized male patient for persistent fever and new respiratory symptoms. The patient is currently on day of induction chemotherapy for acute lymphoblastic leukemia. His hospital course has been complicated by profound neutropenia. Three days prior, after recording a temperature of (), he was started on empiric intravenous piperacillin-tazobactam. Despite this intervention, his fevers have remained unremitting. This morning, he developed right-sided pleuritic chest pain and experienced an episode of hemoptysis. Current vital signs include a temperature of (), blood pressure of , pulse of , and respiratory rate of . Pulse oximetry shows on room air. Pulmonary auscultation reveals focal crackles and decreased breath sounds in the right upper lung zone. Laboratory analysis demonstrates a leukocyte count of with an absolute neutrophil count of . A high-resolution non-contrast computed tomography scan of the chest reveals a right upper lobe dense macroscopic nodule surrounded by a peripheral zone of ground-glass attenuation. Which of the following is the most appropriate next step in the pharmacologic management of this patient?
- AInitiate intravenous vancomycin
- BInitiate intravenous meropenem
- CInitiate intravenous furosemide
- Initiate intravenous voriconazoleCevap
- EInitiate intravenous fluconazole